SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-000653
Filing Date
2024-01-04
Accepted
2024-01-04 17:15:29
Documents
1
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01042024_050112.html 4  
1 form4-01042024_050112.xml 4 9124
  Complete submission text file 0001415889-24-000653.txt   10807
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O COMPETITIVE TECHNOLOGIES, INC. 777 COMMERCE DRIVE, SUITE 100 FAIRFIELD CT 06825
Business Address
DUNBAR GEORGE W JR (Reporting) CIK: 0001194712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 24513255